Article: First-line combination of dasatinib and Peg-IFNα2b in chronic phase CML

2.42

SKU: product-article-17956 Category:

Description

First-line combination of dasatinib and Peg-IFNα2b in chronic phase CML

Reviews

There are no reviews yet.

Be the first to review “Article: First-line combination of dasatinib and Peg-IFNα2b in chronic phase CML”

Your email address will not be published. Required fields are marked *